Facilitated By

San Antonio Medical Foundation

News

  • Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment ...

    We thank the scientists, clinicians, investors and biotech executives ... eRapaTM was originally developed at University of Texas Health San Antonio ...

  • Device for detecting retinal disease takes top prize in UTSA's spring Tech Symposium

    The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community ...

  • Range of city charter proposals include council raises and uncapped city manager pay

    Bioscience-Medicine · Border & Immigration ... Bioscience-Medicine ... Members of the San Antonio Charter Review Commission listen to a presentation from ...

  • Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering

    Contacts: Investors and Media Scilex Holding Company 960 San Antonio Road ... Biotech Bay · Biotech Beach · BioCapital · BioMidwest · Bio NC · BioForest ...

  • Life sciences tools maker to pare 10% of workforce in latest biotech industry cuts

    San Antonio · San Francisco · Seattle · Silicon ... Life sciences tools maker to pare 10% of workforce in latest biotech ... What Genentech parent Roche's ...